Financial News
Pfizer COVID-19 vaccine efficacy drops to 84% after 6 months, preprint study suggests
July 28, 2021 at 15:13 PM EDT
A new study involving the Pfizer-BioNTech COVID-19 vaccine suggests the jab’s efficacy drops to around 84% about six months after the second dose.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
